The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy

Authors :: Jennifer E. Kim
Mira A. Patel
Gordon Li
Michael Lim
Jacob Ruzevick
Source :: Cancers, Vol 6, Iss 4, Pp 1953-1985 (2014), Cancers
Publication Year :: 2014
Publisher :: MDPI AG, 2014.
Abstract: The current standard of care for glioblastoma (GBM) is maximal surgical resection with adjuvant radiotherapy and temozolomide (TMZ). As the 5-year survival with GBM remains at a dismal

Tools